Form 4: Myomo Inc. Chief Medical Officer Reports Stock Disposal for Tax Obligations
SEC Form 4 Filing
Harry Kovelman, Chief Medical Officer of Myomo, Inc., disposed of shares to cover income taxes resulting from a restricted stock unit vesting.
Summary
- On July 3, 2024, Harry Kovelman, the Chief Medical Officer of Myomo, Inc., disposed of 121 shares of common stock at a price of $2.85 per share.
- The transaction was executed to cover income tax obligations arising from the vesting of a restricted stock unit grant on July 2, 2024.
- This disposal was made pursuant to an irrevocable election made by Kovelman in conjunction with the original grant in November 2020.
- Following the reported transaction, Kovelman beneficially owns 132,552 shares of Myomo, Inc.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine transaction to cover tax obligations, not indicative of a major positive or negative outlook.
Industry Context
This is a routine Form 4 filing, reflecting an insider's stock disposal to cover tax obligations related to vested equity. It's a common practice and doesn't necessarily indicate a change in the executive's confidence in the company.
Key Dates
| Date | Description |
|---|---|
| November 2020 | Original grant of restricted stock units. |
| July 2, 2024 | Restricted stock unit vesting date. |
| July 3, 2024 | Date of stock disposal to cover income taxes. |
| 07/08/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.